FOXO4 and B-cell non-Hodgkin lymphoma: Increased expression of FOXO4 in phenylbutyrate-treated surviving cells was confirmed in three B-cell lymphoma cell lines (BJAB, Raji and Daudi) and this increased expression of FOXO4 was also found in vorinostat-treated surviving cells (Figure 3B, 3C).